Bhumit Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.84 M
- Revenue Growth -76.08%
- Profit Growth -56.32%
- Ebitda 16.47%
- Net Worth 8.69%
- Total Assets -20.87%
About Bhumit Pharma
Bhumit Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 2012 and has a history of 12 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.84 M.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100MH2012PTC238727
-
Company No.
238727
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Dec 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Bhumit Pharma Private Limited offer?
Bhumit Pharma Private Limited offers a wide range of products and services, including Cough Syrup, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Common Disease Medicines, Skin Ointment, Anti Infective Drugs & Medicines, Malaria Medicine, Multivitamin Tablets & Capsules, Vitamin B Complex Tablets & Capsules, Dietary Supplements.
Who are the key members and board of directors at Bhumit Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Upadhyay
|
Director | 12-Dec-2012 | Current |
|
Manoj Haushila
|
Director | 12-Dec-2012 | Current |
Financial Performance of Bhumit Pharma.
Bhumit Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 76.08% decrease. The company also saw a substantial fall in profitability, with a 56.32% decrease in profit. The company's net worth moved up by a moderate rise of 8.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhumit Pharma?
In 2023, Bhumit Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.84 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Nov 2020 | Hdfc Bank Limited | ₹3.84 M | Open |
How Many Employees Work at Bhumit Pharma?
Unlock and access historical data on people associated with Bhumit Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhumit Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhumit Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.